Es gab 50 kürzliche Insider-Transaktionen für Alumis Inc. Common Stock (ALMS), darunter 46 Käufe und 3 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $94.64M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Tananbaum James B., Foresite Capital Management Vi Llc, Foresite Labs, Llc. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ALMS
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-04-01 |
Tananbaum James B. |
10 Percent Owner |
Sonstige (Verkauf) |
1,123,337 |
- |
- |
- |
| 2026-04-01 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Sonstige (Verkauf) |
1,123,337 |
- |
- |
- |
| 2026-04-01 |
Foresite Labs, Llc |
10 Percent Owner |
Sonstige (Verkauf) |
1,123,337 |
- |
- |
- |
| 2026-01-26 |
Babler Martin |
President, CEO and Chairman |
RSU-Zuteilung |
745,875 |
$26.31 |
$19.62M |
745,875 |
| 2026-01-26 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
RSU-Zuteilung |
190,875 |
$26.31 |
$5.02M |
190,875 |
| 2026-01-26 |
Schroer John R. |
Chief Financial Officer |
RSU-Zuteilung |
202,225 |
$26.31 |
$5.32M |
202,225 |
| 2026-01-26 |
Goldstein David M |
Chief Scientific Officer |
RSU-Zuteilung |
216,675 |
$26.31 |
$5.7M |
216,675 |
| 2026-01-26 |
Drappa Jorn |
Chief Medical Officer |
RSU-Zuteilung |
221,450 |
$26.31 |
$5.83M |
221,450 |
| 2026-01-26 |
Bradley Mark Christopher |
Chief Development Officer |
RSU-Zuteilung |
190,225 |
$26.31 |
$5M |
190,225 |
| 2026-01-26 |
Pangali Sanam |
Chief Legal Officer |
RSU-Zuteilung |
186,200 |
$26.31 |
$4.9M |
186,200 |
| 2026-01-09 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
588,235 |
$17.00 |
$10M |
1,853,488 |
| 2026-01-08 |
Tananbaum James B. |
10 Percent Owner |
Informierter Kauf |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2026-01-08 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informierter Kauf |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2026-01-08 |
Foresite Labs, Llc |
10 Percent Owner |
Informierter Kauf |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2025-12-31 |
Goldstein David M |
Chief Scientific Officer |
Unbekannt |
- |
- |
- |
8,994 |
| 2025-12-05 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
64,969 |
$8.95 |
$581.47K |
1,143,845 |
| 2025-12-04 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
66,027 |
$8.18 |
$540.1K |
1,078,876 |
| 2025-12-03 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
100,000 |
$7.75 |
$775K |
1,012,849 |
| 2025-12-02 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
96,000 |
$7.55 |
$724.8K |
912,849 |
| 2025-12-01 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
86,350 |
$7.46 |
$644.17K |
816,849 |
| 2025-11-28 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
38,702 |
$7.64 |
$295.68K |
730,499 |
| 2025-11-26 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
48,537 |
$7.64 |
$370.82K |
691,797 |
| 2025-11-21 |
Tananbaum James B. |
10 Percent Owner |
Informierter Kauf |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-21 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informierter Kauf |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-21 |
Foresite Labs, Llc |
10 Percent Owner |
Informierter Kauf |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-20 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
125,743 |
$7.20 |
$905.35K |
643,260 |
| 2025-11-19 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
137,772 |
$6.56 |
$903.78K |
517,517 |
| 2025-11-19 |
Tananbaum James B. |
10 Percent Owner |
Informierter Kauf |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-19 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informierter Kauf |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-19 |
Foresite Labs, Llc |
10 Percent Owner |
Informierter Kauf |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-18 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
102,652 |
$6.05 |
$621.04K |
379,745 |
| 2025-11-18 |
Tananbaum James B. |
10 Percent Owner |
Informierter Kauf |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-18 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informierter Kauf |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-18 |
Foresite Labs, Llc |
10 Percent Owner |
Informierter Kauf |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-17 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
914 |
$5.51 |
$5.04K |
277,093 |
| 2025-11-17 |
Tananbaum James B. |
10 Percent Owner |
Informierter Kauf |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-17 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Informierter Kauf |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-17 |
Foresite Labs, Llc |
10 Percent Owner |
Informierter Kauf |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-13 |
Akkaraju Srinivas |
Director |
Informierter Kauf |
276,179 |
$5.25 |
$1.45M |
276,179 |
| 2025-07-30 |
Akkaraju Srinivas |
Director |
RSU-Zuteilung |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Machado Patrick |
Director |
RSU-Zuteilung |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Yao Zhengbin |
Director |
RSU-Zuteilung |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Srivastava Sapna |
Director |
RSU-Zuteilung |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Tetrault Lynn A. |
Director |
RSU-Zuteilung |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-29 |
Babler Martin |
President, CEO and Chairman |
RSU-Zuteilung |
150,000 |
$3.95 |
$592.5K |
150,000 |
| 2025-07-29 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
RSU-Zuteilung |
111,950 |
$3.95 |
$442.2K |
111,950 |
| 2025-07-29 |
Schroer John R. |
Chief Financial Officer |
RSU-Zuteilung |
28,000 |
- |
- |
28,000 |
| 2025-07-29 |
Goldstein David M |
Chief Scientific Officer |
RSU-Zuteilung |
27,000 |
- |
- |
29,115 |
| 2025-07-29 |
Drappa Jorn |
Chief Medical Officer |
RSU-Zuteilung |
25,450 |
- |
- |
28,450 |
| 2025-07-29 |
Richardson Derrick |
SVP, People and Culture |
RSU-Zuteilung |
42,800 |
- |
- |
42,800 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
